About Concateno
Concateno is a company based in Wynnum (Australia) founded in 2015 was acquired by Abbott in June 2009. Concateno operates in a competitive market with competitors including ICCR-Roßdorf, Myriamed, LeyshonBanks Toxicology, Mammoth Capital Ventures and Essem Compliance, among others.
- Headquarter Wynnum, Australia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Abbott
(Jun 05, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Concateno
Detailed funding history for Concateno
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Concateno
Concateno has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott Global Point of Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Rapid diagnostics products and solutions for point-of-care testing are provided.
|
Locked | Locked | Locked |
Investor details for Concateno
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Concateno
Investment portfolio details for Concateno
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Concateno
Detailed financials for Concateno
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Concateno Comparisons
Peer comparison for Concateno
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Concateno
Concateno operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ICCR-Roßdorf, Myriamed, LeyshonBanks Toxicology, Mammoth Capital Ventures and Essem Compliance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of reliable and high-quality toxicological services
|
|
| Locked | Locked | Locked |
Provides platforms for drug discovery and testing in biotechnology and life sciences.
|
|
| Locked | Locked | Locked |
Offers contract research services for toxicology studies.
|
|
| Locked | Locked | Locked |
Mammoth Capital Ventures is a CRO specializing in toxicology services for healthcare and pharmaceutical clients.
|
|
| Locked | Locked | Locked |
A clinical research organization providing GLP-compliant testing for pharmaceutical and chemical industries.
|
Detailed competitors of Concateno
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Concateno
Complete news archive for Concateno
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concateno
Concateno was founded in 2015.
Concateno is headquartered in Wynnum, Australia. It is registered at Wynnum, Queensland, Australia.
Concateno was established in 2015 and is based in Wynnum, Australia. Drug research and development services are delivered to the biopharma sector, supporting various stages of pharmaceutical innovation. Operations encompass preclinical testing, formulation development, and analytical services. The company maintains a focus on regulatory compliance and quality standards within the Australian life sciences landscape, serving international clients through its specialized expertise.
Concateno's top competitors include ICCR-Roßdorf, Myriamed and LeyshonBanks Toxicology.
Concateno has 1 investor. Key investors include Abbott Global Point of Care.